China Digital Therapeutics Market Size & Outlook
China digital therapeutics market, 2018-2030 (US$M)
Related Markets
China digital therapeutics market highlights
- The China digital therapeutics market generated a revenue of USD 475.5 million in 2023 and is expected to reach USD 2,936.5 million by 2030.
- The China market is expected to grow at a CAGR of 29.7% from 2024 to 2030.
- In terms of segment, diabetes was the largest revenue generating application in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
Digital therapeutics market data book summary
| Market revenue in 2023 | USD 475.5 million |
| Market revenue in 2030 | USD 2,936.5 million |
| Growth rate | 29.7% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
| Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
Other key industry trends
- In terms of revenue, China accounted for 7.6% of the global digital therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China digital therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 149.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 30.18% in 2023. Horizon Databook has segmented the China digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
China is a leading country in terms of low-cost electronic chip and component production. This is likely to attract more investors to China and other Asian countries. Ease of undertaking business initiatives in Asia Pacific is high due to the overall low manufacturing cost and easy availability of labor, which are other important factors expected to boost the market in this region.
China is a high healthcare spending country, which is likely to expand investment opportunities available. The COVID-19 pandemic generated a digital healthcare boom in the country. China further exhibits high growth opportunities owing to its large population and improving healthcare facilities for untargeted medical needs.
Reasons to subscribe to China digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China digital therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into China digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China digital therapeutics market size, by application, 2018-2030 (US$M)
China Digital Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
